1
|
Maurer M, Casale TB, Saini SS, Ben-Shoshan M, Giménez-Arnau AM, Bernstein JA, Yagami A, Stjepanovic A, Radin A, Staudinger HW, Patel N, Amin N, Akinlade B, Fan C, Bauer D, Yancopoulos GD, Patel K, Mannent LP, Laws E. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials. J Allergy Clin Immunol 2024:S0091-6749(24)00196-9. [PMID: 38431226 DOI: 10.1016/j.jaci.2024.01.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 12/21/2023] [Accepted: 01/15/2024] [Indexed: 03/05/2024]
Abstract
BACKGROUND Chronic spontaneous urticaria (CSU) is a chronic inflammatory disease characterized by recurrent pruritic wheals (hives) and/or angioedema. Patients with CSU could remain symptomatic despite standard-of-care H1 antihistamines (H1-AH) or anti-IgE (omalizumab) treatment. Dupilumab blocks IL-4/IL-13 signaling and is approved for multiple type 2/atopic indications. OBJECTIVE We conducted two phase 3, randomized, placebo-controlled, double-blind trials comparing dupilumab with placebo in patients with symptomatic CSU despite H1-AH. METHODS In LIBERTY-CSU CUPID Study A, patients were omalizumab-naive (n = 138, aged ≥6 years). In Study B, patients were omalizumab-intolerant/incomplete responders (n = 108, aged ≥12 years). The primary end point was either change from baseline over 7 days in the Urticaria Activity Score (UAS7) or Itch Severity Score (ISS7) at week 24, with the other as a key secondary end point, depending on regional regulatory requirements. Studies were pooled for safety assessment. RESULTS In Study A, UAS7 and ISS7 improved with dupilumab versus placebo (difference -8.5 [95% CI, -13.2 to -3.9; P = .0003] and -4.2 [95% CI, -6.6 to -1.8; P = .0005]). In Study B, tested at α = 0.043 after interim analysis, UAS7 improved (difference -5.8 [95% CI, -11.4 to -0.3; P = .0390]), with a numerical trend in ISS7 (difference -2.9 [95% CI, -5.7 to -0.07; nominal P = .0449, not significant]). Pooled safety data were consistent between dupilumab and placebo and with the known dupilumab safety profile. CONCLUSIONS Dupilumab reduced urticaria activity by reducing itch and hives severity in omalizumab-naive patients with CSU uncontrolled with H1-AH. Although the primary end point for Study B was not met, dupilumab effects were small in patients who were omalizumab-intolerant/incomplete responders.
Collapse
Affiliation(s)
- Marcus Maurer
- Institute of Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität, Berlin, and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
| | - Thomas B Casale
- Division of Allergy and Immunology, Department of Medicine, University of South Florida, Tampa, Fla
| | | | - Moshe Ben-Shoshan
- Division of Allergy, Immunology, and Dermatology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada
| | - Ana M Giménez-Arnau
- Department of Dermatology, Hospital del Mar, Institut Mar D'Investigacions Mediques, Universitat Autónoma y Universitat Pompeu Fabra, Barcelona, Spain
| | - Jonathan A Bernstein
- Division of Allergy and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Partner Bernstein Allergy Group and Bernstein Clinical Research Center, Cincinnati, Ohio
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | | | - Allen Radin
- Regeneron Pharmaceuticals Inc, Tarrytown, NY
| | | | | | - Nikhil Amin
- Regeneron Pharmaceuticals Inc, Tarrytown, NY
| | | | | | | | | | | | | | | |
Collapse
|
2
|
Suzuki K, Futamura K, Enomoto N, Kosuge A, Ishihara T, Yagami A. Usefulness of vulcanization accelerator-free nitrile rubber gloves, M-GEN2 (type B). Ann Work Expo Health 2023; 67:1121-1124. [PMID: 37724845 DOI: 10.1093/annweh/wxad056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Indexed: 09/21/2023] Open
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, 3-6-10, Otobashi, Nakagawa-ku, Nagoya, Aichi, 454-8509, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, 3-6-10, Otobashi, Nakagawa-ku, Nagoya, Aichi, 454-8509, Japan
| | - Norihide Enomoto
- Department of Personal Protective Equipment Technology, Midori Anzen Co.Ltd., 5-27-1, Inari, Soka, Saitama, 340-0003, Japan
| | - Atsuko Kosuge
- Department of Personal Protective Equipment Technology, Midori Anzen Co.Ltd., 5-27-1, Inari, Soka, Saitama, 340-0003, Japan
| | - Takuma Ishihara
- Innovative and Clinical Research Promotion Center, Gifu University Hospital, 1-1, Yanagido, Gifu, Gifu, 501-1112, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, 3-6-10, Otobashi, Nakagawa-ku, Nagoya, Aichi, 454-8509, Japan
| |
Collapse
|
3
|
Nishida Y, Yagami A, Takada S, Muramatsu D, Nobuoka Y, Okayama Y. Clinical investigation for the mechanisms of anaphylactic symptoms in osteoarthritis patients after diclofenac etalhyaluronate administration. Mod Rheumatol 2023:road100. [PMID: 37862589 DOI: 10.1093/mr/road100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2023] [Revised: 09/26/2023] [Accepted: 10/11/2023] [Indexed: 10/22/2023]
Abstract
OBJECTIVE To investigate mechanisms of anaphylaxis in patients with osteoarthritis (OA) of knee and hip after diclofenac etalhyaluronate (product name: JOYCLU® [JCL]) intra-articular injection, and to determine the utility of tests to investigate the mechanism involved. METHODS In this observational study in Japan, patients aged ≥20 years with knee or hip OA who received JCL intra-articular injection, experienced anaphylactic symptoms considered related to JCL ("experienced patients") or did not experience allergic symptoms considered related to JCL ("non-experienced patients"). Basophil activation tests (BAT), specific immunoglobulin E (IgE) antibody testing by enzyme-linked immunosorbent assays (ELISA) or immunochromatographic kit, and genome-wide association studies (GWAS) were conducted using patient blood and saliva. RESULTS Thirteen experienced patients and 14 non-experienced patients were tested. Seven experienced patients tested positive by BAT using diclofenac etalhyaluronate (DEH)-containing test substances. Diclofenac (DF)-specific IgE antibodies were detected in 4 of 7 BAT-positive patients, but not in the non-experienced patients. Specific IgE antibody testing by immunochromatographic kit and GWAS showed no clear results. CONCLUSIONS These findings suggest that anaphylaxis occurs after JCL administration via an IgE-mediated mechanism and that DEH may be involved in this mechanism. BAT and DF-specific IgE ELISA may be useful tests for investigating the mechanisms of anaphylactic reactions after JCL administration.
Collapse
Affiliation(s)
- Yoshihiro Nishida
- Department of Rehabilitation Medicine, Rare Cancer Center, Nagoya University Hospital, Nagoya, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan
| | - Shuhei Takada
- Research & Development Division, Seikagaku Corporation, Higashiyamato, Tokyo, Japan
| | - Dai Muramatsu
- Research & Development Division, Seikagaku Corporation, Higashiyamato, Tokyo, Japan
| | - Yuji Nobuoka
- Research & Development Division, Seikagaku Corporation, Tokyo, Japan
| | - Yoshimichi Okayama
- Department of Internal Medicine, Division of Allergology, Misato Kenwa Hospital, Misato, Saitama, Japan
- Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University, Tokyo, Japan
- Department of Internal Medicine, Division of Respiratory Medicine, Nihon University School of Medicine, Tokyo, Japan
- Gunma Paz University Graduate School of Health Sciences, Takasaki, Gunma, Japan
| |
Collapse
|
4
|
Aoki Y, Yagami A, Sakai T, Ohno S, Sato N, Nakamura M, Futamura K, Suzuki K, Horiguchi T, Nakata S, Matsunaga K. Alpha/Beta Gliadin MM1 Is a Novel Antigen for Wheat-Dependent Exercise-Induced Anaphylaxis. Int Arch Allergy Immunol 2023; 184:1022-1035. [PMID: 37473737 DOI: 10.1159/000531056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Accepted: 05/05/2023] [Indexed: 07/22/2023] Open
Abstract
INTRODUCTION Screening for ω-5 gliadin specific IgE antibody (sIgE) has high diagnostic utility in cases of suspected wheat-dependent exercise-induced anaphylaxis (WDEIA); however, negative cases may require confirmatory tests, such as the oral challenge test. Thus, newly identified allergens that can be used for the serological diagnosis of WDEIA are needed. This study aimed to identify additional sIgE biomarkers of WDEIA. METHODS Forty-two patients with WDEIA (5 negative/37 positive for ω-5 gliadin sIgE) were enrolled. For comparison, 8 patients with immediate-type wheat allergy without WDEIA and 20 healthy controls without wheat allergy were also enrolled. Extracted wheat proteins were separated by 2D-PAGE. Proteins that reacted with serum IgE antibody in 2D Western blotting (2D-WB) were identified using mass spectrometry. Recombinant proteins were synthesized in Escherichia coli, and the antigenicity was tested using ELISA and the basophil activation test. RESULTS In 2D-WB, nine proteins reacted with the serum IgE antibody from at least 60% of patients with WDEIA (n ≥ 25/42). ELISA revealed that alpha/beta gliadin MM1 exhibited the highest positive immunoreactivity in 23 of 26 patients who were positive for ω-5 gliadin sIgE (88%) and in 5 of 5 patients who were negative for ω-5 gliadin sIgE (100%). Alpha/beta gliadin MM1 exhibited significantly higher basophil activation in 14 patients with WDEIA when compared to 5 individuals without a wheat allergy. CONCLUSIONS Alpha/beta gliadin MM1 sIgE exhibited the highest seropositivity, even among patients who were negative for ω-5 gliadin sIgE. The inclusion of alpha/beta gliadin MM1 in allergen-sIgE tests may improve the sensitivity for diagnosing WDEIA.
Collapse
Affiliation(s)
- Yuji Aoki
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- Department of Otolaryngology, Fujita Health University School of Medicine, Nagoya, Japan
- General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Tomomi Sakai
- General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Satoshi Ohno
- Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan
- Department of Respiratory Medicine, Center for One Medicine, Toyota Regional Medical Center, Toyota, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Takahiko Horiguchi
- General Allergy Center, Fujita Health University, Nagoya, Japan
- Department of Respiratory Medicine, Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan
| | - Seiichi Nakata
- Department of Otolaryngology, Fujita Health University School of Medicine, Nagoya, Japan
- General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| |
Collapse
|
5
|
Hamada M, Sato N, Nakamura M, Shimojo N, Aoki Y, Yagami A, Kondo Y, Matsunaga K. Cross-antigen analysis for allergies to multiple legumes (azuki beans, runner beans, white pea beans). Allergol Int 2023; 72:182-184. [PMID: 36192326 DOI: 10.1016/j.alit.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 08/16/2022] [Accepted: 08/24/2022] [Indexed: 01/25/2023] Open
Affiliation(s)
- Masaaki Hamada
- Department of Pediatrics, Yao Municipal Hospital, Osaka, Japan.
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Naoshi Shimojo
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Yuji Aoki
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan; Fujita Health University General Allergy Center, Bantane Hospital, Aichi, Japan
| | - Yasuto Kondo
- Fujita Health University General Allergy Center, Bantane Hospital, Aichi, Japan; Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| |
Collapse
|
6
|
Kojima H, Nakada T, Yagami A, Todo H, Nishimura J, Yagi M, Yamamoto K, Sugiyama M, Ikarashi Y, Sakaguchi H, Yamaguchi M, Hirota M, Aizawa S, Nakagawa S, Hagino S, Hatao M. A step-by-step approach for assessing acute oral toxicity without animal testing for additives of quasi-drugs and cosmetic ingredients. Curr Res Toxicol 2022; 4:100100. [PMID: 36619289 PMCID: PMC9816657 DOI: 10.1016/j.crtox.2022.100100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 12/05/2022] [Accepted: 12/20/2022] [Indexed: 12/24/2022] Open
Abstract
Animal testing of cosmetic ingredients and products has been banned in the European Union since 2013. However, in Japan, the application of new quasi-drugs requires the generation of data on acute oral toxicity through animal testing. A weight of evidence approach for assessing oral toxicity was challenged. This approach used a combination of safety data, including a neutral red uptake cytotoxicity assay using BALB/c3T3 cells (3T3-NRU cytotoxicity assay), which can assess the acute oral toxicity of quasi-drugs or cosmetic ingredients. We conclude that the step-by-step approach can be used to assess test substances that cause low acute oral toxicity, such as the median lethal dose (LD 50) > 2000 mg/kg, thereby avoiding animal testing.
Collapse
Affiliation(s)
- Hajime Kojima
- National Institute of Health Sciences, Japan,Corresponding author at: 3-25-26 Tonoma-chi, Kawasaki-ku, Kawasaki 210-9501, Japan.
| | | | - Akiko Yagami
- Fujita Health University School of Medicine, Japan
| | | | | | - Mio Yagi
- Pharmaceuticals and Medical Devices Agency, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Suzuki K, Nakamura M, Sato N, Futamura K, Matsunaga K, Yagami A. Nattokinase, a subtilisin family serine protease, is a novel allergen contained in the traditional Japanese fermented food natto. Allergol Int 2022; 72:279-285. [PMID: 36517353 DOI: 10.1016/j.alit.2022.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Revised: 11/14/2022] [Accepted: 11/15/2022] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Immediate allergy caused by natto, a popular Japanese food prepared by fermenting soybeans with Bacillus subtilis var. natto, has been reported. Polygamma glutamic acid (PGA) in the sticky substance around natto beans has been reported to be a causative allergen of natto allergy. However, some of our patients with natto allergy were negative for PGA in the skin prick test (SPT). The sticky substance of natto beans contains a subtilisin family serine protease, nattokinase, along with PGA. In this study, we aimed to examine the antigenicity of nattokinase in natto allergy. METHODS Eight patients, who developed symptoms after ingesting natto and positively reacted to natto (seven to the sticky substance in natto and one to the whole natto product) in their SPT, were enrolled in this study. To analyze IgE reactivity, we performed immunoblotting, ELISA, and SPT for natto (bean and sticky substance), and/or PGA, and/or nattokinase and/or cultured B. subtilis var. natto extract. RESULTS In the SPT, four cases each were PGA-positive and PGA-negative. Immunoblotting of the sera from PGA-negative patients showed a protein band at 30 kDa, which was identified as nattokinase. Three PGA-negative cases, but not three PGA-positive cases, showed a positive reaction to nattokinase in the SPT and had a history of atopic dermatitis. The ELISA for nattokinase revealed a positive reaction of PGA-negative cases and negative reaction of PGA-positive cases in the SPT. CONCLUSIONS We identified a subtilisin family serine protease, nattokinase, as a novel allergen in natto allergy patients unsensitized to PGA.
Collapse
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan.
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan; Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| |
Collapse
|
8
|
Akaza N, Takasaki K, Nishiyama E, Usui A, Miura S, Yokoi A, Futamura K, Suzuki K, Yashiro Y, Yagami A. The Microbiome in Comedonal Contents of Inflammatory Acne Vulgaris is Composed of an Overgrowth of Cutibacterium Spp. and Other Cutaneous Microorganisms. Clin Cosmet Investig Dermatol 2022; 15:2003-2012. [PMID: 36172249 PMCID: PMC9510696 DOI: 10.2147/ccid.s379609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Accepted: 08/25/2022] [Indexed: 11/23/2022]
Abstract
Background Acne vulgaris (acne) and cutaneous resident microorganisms are considered to be closely related. However, the bacterial and fungal microbiota in the comedonal contents of inflammatory acne lesions have not yet been investigated in detail. Purpose To clarify the relationship between cutaneous microorganisms and acne, we examined the microbiome in the comedonal contents of inflammatory acne and on the facial skin of patients with acne using 16s rRNA and ITS gene sequencing with a next-generation sequencer (NGS). Patients and Methods Twenty-two untreated Japanese acne outpatients were examined. The comedonal contents of inflammatory acne lesions on the face were collected using a comedo extractor. Skin surface samples from facial skin were collected using the swab method. Results The results obtained revealed that the predominant bacteria in the comedonal contents of inflammatory acne were Cutibacterium spp. (more prominent in areas with large amounts of sebum), while those on the skin surface were Staphylococcus spp. Malassezia spp., particularly Malassezia restricta, were the predominant fungi in both the comedonal contents of inflammatory acne and on the skin surface. The bacterial microbiome in comedonal contents exhibited stronger metabolic activity, including the production of enzymes related to acne, than that on the skin surface. Conclusion These results indicate that acne is an inflammatory disease involving the overgrowth of Cutibacterium acnes and other cutaneous resident microorganisms, including Malassezia spp.
Collapse
Affiliation(s)
- Narifumi Akaza
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | | | | | | | - Shiori Miura
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Aya Yokoi
- Nihombashi Irodori Dermatology Clinic, Tokyo, Japan.,Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Youichi Yashiro
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| |
Collapse
|
9
|
Suzuki K, Futamura K, Sugiyama M, Matsunaga K, Yagami A. Allergic contact dermatitis caused by dimethicodiethylbenzalmalonate (polysilicone‐15, Parsol
SLX
) and bis‐ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S) in sunscreen cream. Contact Dermatitis 2022; 87:108-110. [DOI: 10.1111/cod.14112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 03/14/2022] [Accepted: 03/15/2022] [Indexed: 11/27/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology Fujita Health University School of Medicine Nagoya Aichi Japan
- General Allergy Center Fujita Health University Nagoya Aichi Japan
- Association of Skin Safety Case Information Network (SSCI‐Net) Nagoya Aichi Japan
| | - Kyoko Futamura
- Department of Allergology Fujita Health University School of Medicine Nagoya Aichi Japan
- General Allergy Center Fujita Health University Nagoya Aichi Japan
| | - Mariko Sugiyama
- Association of Skin Safety Case Information Network (SSCI‐Net) Nagoya Aichi Japan
- Department of Integrative Medical Science for Allergic Disease Fujita Health University School of Medicine Nagoya Aichi Japan
| | - Kayoko Matsunaga
- Association of Skin Safety Case Information Network (SSCI‐Net) Nagoya Aichi Japan
- Department of Integrative Medical Science for Allergic Disease Fujita Health University School of Medicine Nagoya Aichi Japan
| | - Akiko Yagami
- Department of Allergology Fujita Health University School of Medicine Nagoya Aichi Japan
- General Allergy Center Fujita Health University Nagoya Aichi Japan
- Association of Skin Safety Case Information Network (SSCI‐Net) Nagoya Aichi Japan
| |
Collapse
|
10
|
Suzuki K, Futamura K, Nishimura A, Matsunaga K, Yagami A. Seven cases of allergic contact dermatitis due to the use of cosmetics containing 3-O-ethyl-L-ascorbic acid. Contact Dermatitis 2022; 86:421-423. [PMID: 34994407 DOI: 10.1111/cod.14040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 01/03/2022] [Accepted: 01/04/2022] [Indexed: 11/30/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,General Allergy Center, Fujita Health University, Nagoya, Aichi, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,General Allergy Center, Fujita Health University, Nagoya, Aichi, Japan
| | - Asako Nishimura
- Department of Clinical Pharmacy, Doshisha Women's College of Liberal Arts, Kyoto, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,General Allergy Center, Fujita Health University, Nagoya, Aichi, Japan
| |
Collapse
|
11
|
Washio K, Nakamura M, Sato N, Hori M, Matsubara K, Ogura K, Oda Y, Fukunaga A, Yagami A, Matsunaga K. Anaphylaxis in a pectin- and cashew nut-allergic child caused by a citrus bath. Allergol Int 2022; 71:155-157. [PMID: 34353728 DOI: 10.1016/j.alit.2021.07.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 06/11/2021] [Accepted: 06/29/2021] [Indexed: 11/26/2022] Open
|
12
|
Ito A, Suzuki K, Matsunaga K, Yagami A, Ito T, Tamagawa-Mineoka R, Adachi A, Sugiura M, Miyazawa H, Kato A, Nakada T, Nishioka K, Kubota Y, Matsukura S, Watanabe Y, Asada H, Kanto H. Patch testing with the Japanese baseline series 2015: a four-year experience. Contact Dermatitis 2021; 86:189-195. [PMID: 34921568 DOI: 10.1111/cod.14027] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Revised: 12/09/2021] [Accepted: 12/13/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND The Japanese baseline series (JBS), established in 1994, was updated in 2008 and in 2015. The JBS 2015 is a modification of the Thin-layer Rapid Use Epicutaneous (TRUE) test (SmartPractice Denmark, Hillerød, Denmark). No nationwide studies concerning the TRUE test have previously been reported. OBJECTIVES To determine the prevalence of sensitizations to JBS 2015 allergens from 2015 to 2018. METHODS We investigated JBS 2015 patch test results using the web-registered Skin Safety Case Information-Net (SSCI-Net) from April 2015 to March 2019. RESULTS Patch test results of 5865 patients were registered from 63 facilities. The five allergens with the highest positivity rates were gold sodium thiosulfate (GST, 25.7%), nickel sulfate (24.5%), urushiol (9.1%), p-phenylene diamine (PPD, 8.9%) and cobalt chloride (8.4%). The five allergens with the lowest positivity rates were mercaptobenzothiazole (0.8%), formaldehyde (0.9%), paraben mix (1.1%), mercapto mix (1.1%), and PPD black rubber mix (1.4%). CONCLUSIONS Nickel sulfate and GST had the highest positivity rates. The JBS 2015, including a modified TRUE test, is suitable for baseline series patch testing. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Akiko Ito
- Department of Dermatology, Nagata Clinic, Niigata, Niigata, Japan.,Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan
| | - Kayoko Suzuki
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan
| | - Kayoko Matsunaga
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan
| | - Akiko Yagami
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan
| | - Takashi Ito
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Toho University Omori Medical Center, Tokyo, Japan
| | - Risa Tamagawa-Mineoka
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan
| | - Atsuko Adachi
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Hyogo, Japan
| | - Mariko Sugiura
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Environmental Dermatology & Allergology, Daiichi Clinic, Nagoya, Aichi, Japan
| | - Hitoshi Miyazawa
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Nishi-Sapporo Skin and Allergy Clinic, Sapporo, Hokkaido, Japan
| | - Atsuko Kato
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Gokeikai Osaka Kaisei Hospital, Osaka, Osaka, Japan
| | - Tokio Nakada
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan
| | - Kazue Nishioka
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Joy Dermatological Clinic, Sanyo-Onoda, Yamaguchi, Japan
| | - Yumiko Kubota
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Fukuoka Sanno Hospital, Fukuoka, Fukuoka, Japan
| | - Setsuko Matsukura
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Kanagawa, Japan
| | - Yuko Watanabe
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Watanabe Skin and Plastic Surgery Clinic, Matsuyama, Ehime, Japan
| | - Hideo Asada
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Nara, Japan
| | - Hiromi Kanto
- Japanese Contact Dermatitis Research Group, Nagoya, Aichi, Japan.,Department of Dermatology, Toho University Omori Medical Center, Tokyo, Japan
| |
Collapse
|
13
|
Shimojo N, Yagami A, Ohno F, Tsurumi Y, Nakamura M, Suzuki K, Kuwabara K, Futamura K, Ohno S, Yokogawa T, Horiguchi T, Matsunaga K. Fish collagen as a potential indicator of severe allergic reactions among patients with fish allergies. Clin Exp Allergy 2021; 52:183-187. [PMID: 34624151 DOI: 10.1111/cea.14028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Revised: 09/22/2021] [Accepted: 09/25/2021] [Indexed: 12/01/2022]
Affiliation(s)
- Naoshi Shimojo
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.,General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | - Fumiaki Ohno
- General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Yuta Tsurumi
- General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.,General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | - Kazunobu Kuwabara
- Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan.,Department of Respiratory Medicine II, Fujita Health University School of Medicine, Nagoya, Japan.,Department of Internal Medicine/Respiratory Medicine, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | - Satoshi Ohno
- Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan
| | - Takashi Yokogawa
- Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan
| | - Takahiko Horiguchi
- Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan.,Department of Respiratory Medicine II, Fujita Health University School of Medicine, Nagoya, Japan.,Respiratory Medicine, Toyota Regional Medical Center, Toyota, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| |
Collapse
|
14
|
Fukunaga K, Chinuki Y, Hamada Y, Fukutomi Y, Sugiyama A, Kishikawa R, Fukunaga A, Oda Y, Ugajin T, Yokozeki H, Harada N, Suehiro M, Hide M, Nakagawa Y, Noguchi E, Nakamura M, Matsunaga K, Yagami A, Morita E, Mushiroda T. Genome-wide association study reveals an association between the HLA-DPB1 ∗02:01:02 allele and wheat-dependent exercise-induced anaphylaxis. Am J Hum Genet 2021; 108:1540-1548. [PMID: 34246321 PMCID: PMC8387458 DOI: 10.1016/j.ajhg.2021.06.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Accepted: 06/15/2021] [Indexed: 12/27/2022] Open
Abstract
Wheat-dependent exercise-induced anaphylaxis (WDEIA) is a life-threatening food allergy triggered by wheat in combination with the second factor such as exercise. The identification of potential genetic risk factors for this allergy might help high-risk individuals before consuming wheat-containing food. We aimed to identify genetic variants associated with WDEIA. A genome-wide association study was conducted in a discovery set of 77 individuals with WDEIA and 924 control subjects via three genetic models. The associations were confirmed in a replication set of 91 affected individuals and 435 control individuals. Summary statistics from the combined set were analyzed by meta-analysis with a random-effect model. In the discovery set, a locus on chromosome 6, rs9277630, was associated with WDEIA in the dominant model (OR = 3.95 [95% CI, 2.31-6.73], p = 7.87 × 10-8). The HLA-DPB1∗02:01:02 allele displayed the most significant association with WDEIA (OR = 4.51 [95% CI, 2.66-7.63], p = 2.28 × 10-9), as determined via HLA imputation following targeted sequencing. The association of the allele with WDEIA was confirmed in replication samples (OR = 3.82 [95% CI, 2.33-6.26], p = 3.03 × 10-8). A meta-analysis performed in the combined set revealed that the HLA-DPB1∗02:01:02 allele was significantly associated with an increased risk of WDEIA (OR = 4.13 [95% CI, 2.89-5.93], p = 1.06 × 10-14). Individuals carrying the HLA-DPB1∗02:01:02 allele have a significantly increased risk of WDEIA. Further validation of these findings in independent multiethnic cohorts is needed.
Collapse
Affiliation(s)
- Koya Fukunaga
- Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan
| | - Yuko Chinuki
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane 693-0021, Japan
| | - Yuto Hamada
- Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa 252-0392, Japan
| | - Yuma Fukutomi
- Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa 252-0392, Japan
| | - Akiko Sugiyama
- Department of Allergology, National Hospital Organization Fukuoka National Hospital, Fukuoka 810-0062, Japan
| | - Reiko Kishikawa
- Department of Allergology, National Hospital Organization Fukuoka National Hospital, Fukuoka 810-0062, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
| | - Tsukasa Ugajin
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| | - Hiroo Yokozeki
- Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| | - Naoe Harada
- Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
| | - Masataka Suehiro
- Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
| | - Michihiro Hide
- Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
| | - Yukinobu Nakagawa
- Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
| | - Emiko Noguchi
- Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya 454-8509, Japan; General Research and Development Institute, Hoyu, Nagakute 454-8509, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya 454-8509, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya 454-8509, Japan; Fujita Health University General Allergy Center in Bantane Hospital, Nagoya 454-8509, Japan
| | - Eishin Morita
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane 693-0021, Japan.
| | - Taisei Mushiroda
- Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
| |
Collapse
|
15
|
Sato N, Suzuki K, Yagami A, Futamura K, Kobayashi T, Nakamura M, Matsunaga K. Antigen analysis of patients with gastrointestinal symptoms resulting from immediate allergic reactions to mushrooms. Allergol Int 2021; 70:382-385. [PMID: 33832845 DOI: 10.1016/j.alit.2021.02.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 02/15/2021] [Accepted: 02/16/2021] [Indexed: 11/18/2022] Open
Affiliation(s)
- Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan; Fujita Health University General Allergy Center, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan; Fujita Health University General Allergy Center, Aichi, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan; Fujita Health University General Allergy Center, Aichi, Japan
| | - Takashi Kobayashi
- Department of Gastroenterology, Fujita Health University School of Medicine, Aichi, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan; Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan.
| |
Collapse
|
16
|
Suzuki K, Futamura K, Hasegawa E, Aoki Y, Nakamura M, Matsunaga K, Yagami A. Adult-Onset Sheep's Milk Allergy in a Patient Without Cow's Milk Allergy. J Investig Allergol Clin Immunol 2021; 31:273-274. [PMID: 32856594 DOI: 10.18176/jiaci.0578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- K Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - K Futamura
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - E Hasegawa
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Y Aoki
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - M Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - K Matsunaga
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - A Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| |
Collapse
|
17
|
Inoue S, Katayama I, Suzuki T, Tanemura A, Ito S, Abe Y, Sumikawa Y, Yoshikawa M, Suzuki K, Yagami A, Masui Y, Ito A, Matsunaga K. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo. J Dermatol 2021; 48:969-978. [PMID: 33951216 PMCID: PMC8360127 DOI: 10.1111/1346-8138.15878] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 01/29/2021] [Accepted: 03/18/2021] [Indexed: 12/14/2022]
Abstract
A small proportion of individuals utilizing cosmetics containing rhododendrol developed leukoderma with various pathological conditions, in some cases indistinguishable from vitiligo. In this review, we investigate and evaluate the major considerations for developing rhododendrol‐induced leukoderma based on data from original or review articles published in the literature to provide a wide range of information regarding the pathophysiology, mechanisms, risk evaluation, and possible mechanism‐based treatments. We compile and discuss the latest information, including data related to the cytotoxicity of rhododendrol, cytoprotective functions, and involvement of the immune system, and consider the possibility of novel treatments based on the differences between individual patients and on the mechanism underlying the onset of the condition. Understanding the pathophysiology of rhododendrol‐induced leukoderma helps not only elucidate the mechanisms of non‐segmental vitiligo onset and progression, but also suggests prevention and treatment.
Collapse
Affiliation(s)
- Shintaro Inoue
- Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan
| | - Ichiro Katayama
- Department of Pigmentation Research and Therapeutics, Osaka City University, Osaka, Japan
| | - Tamio Suzuki
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Atsushi Tanemura
- Department of Dermatology Course of Integrated Medicine, Osaka University Graduate School of Medicine, Suita, Japan
| | - Shosuke Ito
- Department of Chemistry, Fujita Health University School of Medical Sciences, Toyoake, Japan
| | - Yuko Abe
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Yasuyuki Sumikawa
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.,Sumikawa Dermatology and Allergy Clinic, Sapporo, Japan
| | - Momoko Yoshikawa
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Yukiko Masui
- Departent of Dermatology, Nagata Clinic, Niigata, Japan
| | - Akiko Ito
- Departent of Dermatology, Nagata Clinic, Niigata, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| |
Collapse
|
18
|
Suzuki K, Futamura K, Kawakami T, Numata M, Sasaki K, Matsunaga K, Yagami A. Contact dermatitis caused by a disposable paper napkin containing colophonium. Contact Dermatitis 2021; 85:377-379. [PMID: 33861875 DOI: 10.1111/cod.13864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 04/09/2021] [Accepted: 04/13/2021] [Indexed: 11/27/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,General Allergy Center, Fujita Health University, Nagoya, Japan
| | - Tsuyoshi Kawakami
- Division of Environmental Chemistry, National Institute of Health Sciences, Kawasaki, Japan
| | - Mitsuru Numata
- Administrative Affairs Division, Biological Resource Center, National Institute of Technology and Evaluation, Tokyo, Japan
| | - Kazumi Sasaki
- Administrative Affairs Division, Biological Resource Center, National Institute of Technology and Evaluation, Tokyo, Japan
| | - Kayoko Matsunaga
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan.,General Allergy Center, Fujita Health University, Nagoya, Japan
| |
Collapse
|
19
|
Matsunaga K, Suzuki K, Ito A, Tanemura A, Abe Y, Suzuki T, Yoshikawa M, Sumikawa Y, Yagami A, Masui Y, Inoue S, Ito S, Katayama I. Rhododendrol-induced leukoderma update I: Clinical findings and treatment. J Dermatol 2021; 48:961-968. [PMID: 33686651 PMCID: PMC8359339 DOI: 10.1111/1346-8138.15835] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 01/06/2021] [Accepted: 02/12/2021] [Indexed: 01/09/2023]
Abstract
Individuals who used skin-whitening cosmetics (quasi-drugs) containing 2% rhododendrol-containing agents, developed leukoderma at a higher frequency than those who have used other skin-whitening cosmetics. The Rhododenol Research Team (RD-Team) was formed and commissioned by Kanebo Cosmetics Inc. to conduct research in treatments of rhododendrol-induced leukoderma (RDL), to evaluate effective treatment options from a medical standpoint, and provide information to a wide range of people. In this study, we evaluated the efficacy of various treatments for RDL from a medical perspective, based on the information published in the literature as original or review articles. We searched the PubMed (international) and the Igaku Chuo Zasshi (ICHUSHI) (Japanese) databases using the keywords "Rhododenol" and "rhododendrol", for articles published between July 2013 and November 2020. We discuss the main clinical findings and treatments (topical, oral, phototherapy, and surgical) of this condition based on the literature review. We found that ultraviolet light therapy is the most effective treatment for RDL. We have also summarized reports of the efficacy of oral vitamin D3 in RDL. A topical prostaglandin derivative has been reported in a new study to be effective. We have provided guidance for patients using self-tanning and skin-whitening agents to improve their quality of life. Finally, we have highlighted the importance of providing patients with information on contact dermatitis and instructing them to discontinue product use immediately if they develop any symptoms of contact dermatitis while using skin-whitening agents.
Collapse
Affiliation(s)
- Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Ito
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.,Departent of Dermatology, Nagata Clinic, Niigata, Japan
| | - Atsushi Tanemura
- Department of Dermatology Course of Integrated Medicine, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yuko Abe
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Tamio Suzuki
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Momoko Yoshikawa
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Yasuyuki Sumikawa
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.,SUMIKAWA Dermatology & Allergy CLINIC, Sapporo, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Yukiko Masui
- Departent of Dermatology, Nagata Clinic, Niigata, Japan
| | - Shintaro Inoue
- Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan
| | - Shosuke Ito
- Department of Chemistry, Fujita Health University School of Medical Sciences, Toyoake, Japan
| | - Ichiro Katayama
- Department of Pigmentation Research and Therapeutics, Osaka City University, Osaka, Japan
| |
Collapse
|
20
|
Suzuki K, Matsunaga K, Ito A, Yagami A, Ito T, Miyazawa H, Sugiura M, Adachi A, Kubota Y, Watanabe Y, Kato A, Nishioka K, Fukunaga A, Mochizuki M, Ikezawa Y, Tsunoda T, Takayama K, Washizaki K, Yokozeki H, Ishihara T, Asada H, Kanto H. Multicenter 1-month follow-up study of the patch-test reaction to the gold sodium thiosulfate of the TRUE Test and its association with piercings and dental metal history. Contact Dermatitis 2021; 85:154-163. [PMID: 33660302 DOI: 10.1111/cod.13827] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 02/24/2021] [Accepted: 02/28/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND There is controversy over late and long-lasting reactions to gold sodium thiosulfate (GST). OBJECTIVES To study the GST patch-test reaction by observing the application site after 1 month, and to clarify the relevance of GST sensitization by piercings and dental metals. PATIENTS A retrospective analysis was performed on 746 patients (143 male; 603 female) who were patch tested using GST of the TRUE Test. We conducted a questionnaire on the presence of piercings or dental metals in these patients. RESULTS The GST positive rate was 27.9% at day (D)3 and/or D7 and 40.3% up to the 1-month reading. The positive rate was significantly higher in female patients and increased with age. Sixty-two percent of cases with a positive reaction at D7 continued to show a positive reaction after 1 month. Eleven percent of cases with a negative reaction at D3 and D7 showed a late reaction. Both piercings and dental metals were related to gold sensitization. CONCLUSIONS The GST of the TRUE Test had a high positive and low false-negative rate. The 1-month reading after the patch test was important for identifying late reactions. Piercing history and dental metal were associated with gold sensitization.
Collapse
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
| | - Kayoko Matsunaga
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Ito
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- Department of Dermatology, Nagata Clinic, Niigata, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
| | - Takashi Ito
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Toho University Omori Medical Center, Tokyo, Japan
| | - Hitoshi Miyazawa
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Nishi-Sapporo Skin and Allergy Clinic, Sapporo, Japan
| | - Mariko Sugiura
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Environmental Dermatology & Allergology, Daiichi Clinic, Nagoya, Japan
| | - Atsuko Adachi
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan
| | - Yumiko Kubota
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Fukuoka Sanno Hospital, Fukuoka, Japan
| | - Yuko Watanabe
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Watanabe Skin and Plastic Surgery Clinic, Matsuyama, Japan
| | - Atsuko Kato
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Gokeikai Osaka Kaisei Hospital, Osaka, Japan
| | - Kazue Nishioka
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Joy Dermatological Clinic, Sanyo-Onoda, Japan
| | - Atsushi Fukunaga
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Masako Mochizuki
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Mochizuki Dermatological Clinic, Nagano, Japan
| | - Yuko Ikezawa
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Chigasaki Municipal Hospital, Chigasaki, Japan
| | - Takahiko Tsunoda
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Yamagata City Hospital SAISEIKAN, Yamagata, Japan
| | - Kaoru Takayama
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Kumiko Washizaki
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Omorimachi Dermatology, Tokyo, Japan
| | - Hiroo Yokozeki
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Takuma Ishihara
- Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, Japan
| | - Hideo Asada
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Nara Medical University Hospital, Kashihara, Japan
| | - Hiromi Kanto
- Japanese Contact Dermatitis Research Group, Nagoya, Japan
- Department of Dermatology, Toho University Omori Medical Center, Tokyo, Japan
| |
Collapse
|
21
|
Suzuki K, Futamura K, Sato N, Nakamura M, Matsunaga K, Yagami A. Contact urticaria caused by carmine-containing eyeshadows; the causative allergen is carminic acid rather than CC38K. Contact Dermatitis 2021; 84:468-469. [PMID: 33368352 DOI: 10.1111/cod.13769] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2020] [Accepted: 12/22/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,Fujita Health University General Allergy Center, Nagoya, Aichi, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,Fujita Health University General Allergy Center, Nagoya, Aichi, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Aichi, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.,Fujita Health University General Allergy Center, Nagoya, Aichi, Japan
| |
Collapse
|
22
|
Yagami A. [JAPANESE GUIDELINES FOR DIAGNOSIS AND TREATMENT OF URTICARIA 2018]. Arerugi 2021; 70:1351-1357. [PMID: 34911886 DOI: 10.15036/arerugi.70.1351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- Akiko Yagami
- Department of Allergology, Fujita Health University Second Educational Hospital
| |
Collapse
|
23
|
Suzuki K, Futamura K, Sato N, Nakamura M, Matsunaga K, Yagami A. Two cases of fermented soybean (natto) allergy diagnosed using the skin prick test and enzyme linked immunosorbent assay for poly-γ-glutamic acid. J Dermatol 2020; 47:e429-e430. [PMID: 32892385 DOI: 10.1111/1346-8138.15601] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Revised: 07/21/2020] [Accepted: 08/14/2020] [Indexed: 11/27/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- General Research and Development Institute, Hoyu Co., Ltd, Nagoya, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
- General Research and Development Institute, Hoyu Co., Ltd, Nagoya, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| |
Collapse
|
24
|
Onoda Y, Aoki Y, Nagai A, Hasegawa E, Nakamura M, Suzuki K, Futamura K, Hirosima M, Horiguchi T, Matsunaga K, Yagami A. A case of hen's egg-dependent exercise-induced immediate-type allergy. Allergol Int 2020; 69:476-477. [PMID: 32241627 DOI: 10.1016/j.alit.2020.01.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2019] [Revised: 01/06/2020] [Accepted: 01/22/2020] [Indexed: 11/28/2022] Open
Affiliation(s)
- Yuko Onoda
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Yuji Aoki
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan; Department of Respiratory Medicine II, Fujita Health University School of Medicine, Nagoya, Japan; Department of General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Akiyo Nagai
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Erika Hasegawa
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan; Department of General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan; Department of General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan; Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | - Kyoko Futamura
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan; Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | | | - Takahiko Horiguchi
- Department of Respiratory Medicine II, Fujita Health University School of Medicine, Nagoya, Japan; Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan; Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan; Fujita Health University General Allergy Center in Bantane Hospital, Nagoya, Japan.
| |
Collapse
|
25
|
Okamura K, Abe Y, Naka I, Ohashi J, Yagami A, Matsunaga K, Kobayashi Y, Fukai K, Tanemura A, Katayama I, Masui Y, Ito A, Yamashita T, Nagai H, Nishigori C, Oiso N, Aoyama Y, Araki Y, Saito T, Hayashi M, Hozumi Y, Suzuki T. Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma. Pigment Cell Melanoma Res 2020; 33:826-833. [PMID: 32558222 DOI: 10.1111/pcmr.12904] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Revised: 05/30/2020] [Accepted: 06/09/2020] [Indexed: 11/28/2022]
Abstract
Racemic RS-4-(4-hydroxyphenyl)-2-butanol (rhododendrol; trade name: Rhododenol [RD]), which is used in topical skin-lightening cosmetics, was unexpectedly reported in Japan to induce leukoderma or vitiligo called RD-induced leukoderma (RIL) after repeated application. To our knowledge, no studies have investigated chemical-induced vitiligo pathogenesis on a genome-wide scale. Here, we conducted a genome-wide association study (GWAS) for 147 cases and 112 controls. CDH13, encoding a glycosylphosphatidylinositol-anchored protein called T-cadherin (T-cad), was identified as the strongest RIL susceptibility gene. RD sensitivity was remarkably increased by T-cad knockdown in cultured normal human melanocytes. Furthermore, we confirmed tyrosinase upregulation and downregulation of the anti-apoptotic molecules (BCL-2 and BCL-XL), suggesting that T-cad is associated with RD via tyrosinase or apoptotic pathway regulation. Finally, monobenzyl ether of hydroquinone sensitivity also tended to increase with T-cad knockdown, suggesting that the T-cad could be a candidate susceptibility gene for RIL and other chemical-induced vitiligo forms. This is the first GWAS for chemical-induced vitiligo, and it could be a useful model for studying the disease's genetic aspects.
Collapse
Affiliation(s)
- Ken Okamura
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Yuko Abe
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Izumi Naka
- Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan
| | - Jun Ohashi
- Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, Aichi, Japan.,Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, Aichi, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Yui Kobayashi
- Department of Dermatology, Graduate School of Medicine, Osaka City University, Osaka, Japan
| | - Kazuyoshi Fukai
- Department of Dermatology, Graduate School of Medicine, Osaka City University, Osaka, Japan
| | - Atsushi Tanemura
- Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Ichiro Katayama
- Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.,Department of Pigmentation Research and Therapeutics, Graduate School of Medicine, Osaka City University, Osaka, Japan
| | - Yukiko Masui
- Division of Dermatology, Nagata Clinic, Niigata, Japan.,Department of Dermatology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan
| | - Akiko Ito
- Division of Dermatology, Nagata Clinic, Niigata, Japan.,Department of Dermatology, Niigata University Graduate School of Medicine and Dental Sciences, Niigata, Japan
| | - Toshiharu Yamashita
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Hiroshi Nagai
- Division of Dermatology, Department of Internal Related, Graduate School of Medicine, Kobe University, Hyogo, Japan
| | - Chikako Nishigori
- Division of Dermatology, Department of Internal Related, Graduate School of Medicine, Kobe University, Hyogo, Japan
| | - Naoki Oiso
- Department of Dermatology, Faculty of Medicine, Kinki University, Osaka, Japan
| | - Yumi Aoyama
- Department of Dermatology, Kawasaki Medical School, Okayama, Japan
| | - Yuta Araki
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Toru Saito
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Masahiro Hayashi
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Yutaka Hozumi
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| | - Tamio Suzuki
- Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
| |
Collapse
|
26
|
Nishimura-Tagui M, Hayama K, Fujita H, Sato N, Nakamura M, Yagami A, Matsunaga K, Terui T. Case of anaphylaxis due to lotus root. J Dermatol 2020; 47:e227-e228. [PMID: 32232879 DOI: 10.1111/1346-8138.15329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Maho Nishimura-Tagui
- Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan
| | - Koremasa Hayama
- Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan
| | - Hideki Fujita
- Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.,General Research and Development Institute, Hoyu Co., Ltd., Aichi, Japan
| | - Akiko Yagami
- Deparatment of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Tadashi Terui
- Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan
| |
Collapse
|
27
|
Chinuki Y, Yagami A, Adachi A, Matsunaga K, Ugajin T, Yokozeki H, Hayashi M, Katayama I, Kohno K, Shiwaku K, Morita E. In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy. Allergol Int 2020; 69:284-286. [PMID: 31753713 DOI: 10.1016/j.alit.2019.09.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2019] [Revised: 09/15/2019] [Accepted: 09/16/2019] [Indexed: 11/19/2022] Open
Affiliation(s)
- Yuko Chinuki
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan.
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - Atsuko Adachi
- Department of Dermatology, Hyogo Prefectural Kakogawa Medical Center, Hyogo, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Tsukasa Ugajin
- Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Hiroo Yokozeki
- Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Misa Hayashi
- Department of Dermatology, Osaka General Medical Center, Osaka, Japan
| | - Ichiro Katayama
- Department of Pigmentation Research and Therapeutics, Osaka City University, Osaka, Japan
| | - Kunie Kohno
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan; Center for Community-Based Health Research and Education (COHRE), Organization for Research and Academic Information, Shimane University, Shimane, Japan
| | | | - Eishin Morita
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan
| |
Collapse
|
28
|
Kato M, Yagami A, Tsukamoto T, Shinkai Y, Kato T, Kurahashi H. Novel mutation in the KITLG gene in familial progressive hyperpigmentation with or without hypopigmentation. J Dermatol 2020; 47:669-672. [PMID: 32189379 DOI: 10.1111/1346-8138.15313] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Accepted: 02/18/2020] [Indexed: 11/27/2022]
Abstract
We herein report a novel mutation in familial progressive hyper- and hypopigmentation (FPHH). The KITLG gene encoding the KIT ligand protein is a disease-causing gene for FPHH. Various disease-causing gain-of-function mutations, which reside within or adjacent to the conserved VTNN motif of this gene, have been described to date. We have now identified a novel KITLG mutation, c.337G>A (p.Glu113Lys), in FPHH which is located within another ligand-receptor interaction site.
Collapse
Affiliation(s)
- Maki Kato
- Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Akiko Yagami
- Departments of, Department of, Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Tetsuya Tsukamoto
- Department of, Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Yasuko Shinkai
- Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Takema Kato
- Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| | - Hiroki Kurahashi
- Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan
| |
Collapse
|
29
|
Shimojo N, Yagami A, Aoki Y, Nakamura M, kitano H, suzuki K, Kondo Y, Horiguchi T, Matsunaga K. Development of a clinical research system for allergic diseases, “MINERVA”. J Allergy Clin Immunol 2020. [DOI: 10.1016/j.jaci.2019.12.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
30
|
Kawai M, Kondo Y, Nakajima Y, Tsuge I, Yoshikawa T, Yagami A, Aihara M, Ikezawa Z, Ohya Y, Kitabayashi T, Saito H, Shibata R, Naito T, Harada S, Hide M, Matsunaga K, Miyasaka K, Akasawa A. Changes in the characteristics of patients with latex allergy from 1999 to 2014. Fujita Med J 2020; 6:67-72. [PMID: 35111524 PMCID: PMC8749504 DOI: 10.20407/fmj.2019-013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/15/2019] [Accepted: 09/18/2019] [Indexed: 12/01/2022]
Abstract
OBJECTIVES We conducted a multicenter study using the same questionnaire in 1999 and 2014 to investigate changes in the characteristics of patients with latex allergy. METHODS We mailed questionnaires on latex allergy to hospitals in Japan that were members of the Japanese Latex Allergy Society. RESULTS We compared the 25 responses received in 2014 and the 81 responses received in 1999. With regard to the age distribution, the number of patients with latex allergy in their 20s declined significantly from 1999 to 2014 (P=0.004). The largest proportion of latex allergy cases was observed among those aged <10 years. The incidence of cases caused by medical rubber gloves decreased significantly (P=0.004). Moreover, latex-fruit syndrome increased from 15% to 40% (P=0.006). CONCLUSIONS Our findings indicate that the frequency of occurrence of latex allergy in people in their 20s decreased from 1999 to 2014. The largest proportion of latex allergy cases was observed among those aged <10 years. Future measures to protect children are required.
Collapse
Affiliation(s)
- Manabu Kawai
- Department of Pediatrics, Fujita Health University, School of
Medicine, Toyoake, Aichi, Japan
| | - Yasuto Kondo
- Department of Pediatrics, Fujita Health University Bantane Hospital,
Nagoya, Aichi, Japan
| | - Yoichi Nakajima
- Department of Pediatrics, Fujita Health University, School of
Medicine, Toyoake, Aichi, Japan
| | - Ikuya Tsuge
- Department of Pediatrics, Yachiyo Hospital, Anjo, Aichi,
Japan
| | - Tetsushi Yoshikawa
- Department of Pediatrics, Fujita Health University, School of
Medicine, Toyoake, Aichi, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University Bantane
Hospital, Nagoya, Aichi, Japan
| | - Michiko Aihara
- Department of Dermatology, Yokohama City University School of
Medicine, Yokohama, Kanagawa, Japan
| | | | - Yukihiro Ohya
- National Center for Child Health and Development,
Setagaya, Tokyo, Japan
| | - Taeru Kitabayashi
- Department of Pediatrics, International University of Health and Welfare Mita
Hospital, Minato, Tokyo, Japan
| | - Hirohisa Saito
- Department of Allergy & Immunology, National Center for Child Health and
Development, Setagaya, Tokyo, Japan
| | - Rumiko Shibata
- Department of Pediatrics, Fukuoka National Hospital,
Fukuoka, Fukuoka, Japan
| | - Toru Naito
- Department of General Dentistry, Fukuoka Dental College,
Fukuoka, Fukuoka, Japan
| | - Susumu Harada
- Harada Dermatology Clinic, Nishinomiya, Hyogo,
Japan
| | - Michihiro Hide
- Department of Dermatology, Hiroshima University School of Medicine,
Hiroshima, Hiroshima, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health
University, School of Medicine, Toyoake, Aichi,
Japan
| | | | | |
Collapse
|
31
|
Suzuki K, Matsunaga K, Sasaki K, Yagami A. Allergic contact dermatitis caused by tetrahydrofurfuryl acrylate in the adhesive of clip‐on earrings. Contact Dermatitis 2019; 82:131-133. [DOI: 10.1111/cod.13412] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Accepted: 10/07/2019] [Indexed: 11/29/2022]
Affiliation(s)
- Kayoko Suzuki
- Department of AllergologyFujita Health University School of Medicine Aichi Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic DiseaseFujita Health University School of Medicine Aichi Japan
| | - Kazumi Sasaki
- Department of Biological Resource CenterNational Institute of Technology and Evaluation, Shibuya Tokyo Japan
| | - Akiko Yagami
- Department of AllergologyFujita Health University School of Medicine Aichi Japan
| |
Collapse
|
32
|
Noguchi E, Akiyama M, Yagami A, Hirota T, Okada Y, Kato Z, Kishikawa R, Fukutomi Y, Hide M, Morita E, Aihara M, Hiragun M, Chinuki Y, Okabe T, Ito A, Adachi A, Fukunaga A, Kubota Y, Aoki T, Aoki Y, Nishioka K, Adachi T, Kanazawa N, Miyazawa H, Sakai H, Kozuka T, Kitamura H, Hashizume H, Kanegane C, Masuda K, Sugiyama K, Tokuda R, Furuta J, Higashimoto I, Kato A, Seishima M, Tajiri A, Tomura A, Taniguchi H, Kojima H, Tanaka H, Sakai A, Morii W, Nakamura M, Kamatani Y, Takahashi A, Kubo M, Tamari M, Saito H, Matsunaga K. HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy. J Allergy Clin Immunol 2019; 144:1354-1363. [DOI: 10.1016/j.jaci.2019.06.034] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2018] [Revised: 05/30/2019] [Accepted: 06/27/2019] [Indexed: 12/28/2022]
|
33
|
Hamada Y, Chinuki Y, Fukutomi Y, Nakatani E, Yagami A, Matsunaga K, Oda Y, Fukunaga A, Adachi A, Hiragun M, Hide M, Morita E. Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergy. J Allergy Clin Immunol Pract 2019; 8:1149-1151.e3. [PMID: 31678299 DOI: 10.1016/j.jaip.2019.10.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Received: 06/23/2019] [Revised: 09/16/2019] [Accepted: 10/08/2019] [Indexed: 11/29/2022]
Affiliation(s)
- Yuto Hamada
- Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Kanagawa, Japan; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yuko Chinuki
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan
| | - Yuma Fukutomi
- Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Kanagawa, Japan; Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
| | - Eiji Nakatani
- Division of Medical Statistics, Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, Aichi, Japan; Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Yoshiko Oda
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsushi Fukunaga
- Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Atsuko Adachi
- Department of Dermatology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan
| | - Makiko Hiragun
- Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Michihiro Hide
- Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Eishin Morita
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan
| |
Collapse
|
34
|
Affiliation(s)
- Kayoko Suzuki
- Department of AllergologyFujita Health University Second Educational Hospital Aichi Japan
| | - Akiko Yagami
- Department of AllergologyFujita Health University Second Educational Hospital Aichi Japan
| | - Akiko Ito
- Department of DermatologyNagata Clinic Niigata Japan
- Department of Integrative Medical Science for Allergic DiseaseFujita Health University School of Medicine Aichi Japan
| | - Hiromi Kanto
- Department of Dermatology, School of Medicine, Faculty of MedicineToho University Tokyo Japan
| | - Kayoko Matsunaga
- Department of AllergologyFujita Health University Second Educational Hospital Aichi Japan
- Department of Integrative Medical Science for Allergic DiseaseFujita Health University School of Medicine Aichi Japan
| |
Collapse
|
35
|
Hayashi E, Sowa-Osako J, Fukai K, Natsumi A, Yagami A, Sato N, Shimojo N, Nakamura M, Matsunaga K, Tsuruta D. Case of anaphylaxis caused by black ginger in a dietary supplement. J Dermatol 2019; 46:e56-e57. [PMID: 30152038 DOI: 10.1111/1346-8138.14592] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Eriko Hayashi
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Junko Sowa-Osako
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Kazuyoshi Fukai
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
- Department of Dermatology, Osaka City General Hospital, Osaka, Japan
| | - Aki Natsumi
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
- Department of General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Naoshi Shimojo
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
- Department of General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
- Department of General Research and Development Institute, Hoyu Co., Ltd, Nagakute, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
| | - Daisuke Tsuruta
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
36
|
Yagami A. [FOOD ALLERGY IN ADULTS INCLUDING PFAS, FDEIA, ETC.]. Arerugi 2019; 68:1174-1179. [PMID: 31827023 DOI: 10.15036/arerugi.68.1174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- Akiko Yagami
- Department of Allergology, Fujita Health University Second Educational Hospital
| |
Collapse
|
37
|
Takeo N, Nakamura M, Nakayama S, Okamoto O, Sugimoto N, Sugiura S, Sato N, Harada S, Yamaguchi M, Mitsui N, Kubota Y, Suzuki K, Terada M, Nagai A, Sowa-Osako J, Hatano Y, Akiyama H, Yagami A, Fujiwara S, Matsunaga K. Cochineal dye-induced immediate allergy: Review of Japanese cases and proposed new diagnostic chart. Allergol Int 2018; 67:496-505. [PMID: 29705083 DOI: 10.1016/j.alit.2018.02.012] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 02/13/2018] [Accepted: 02/21/2018] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Cochineal dye is used worldwide as a red coloring in foods, drinks, cosmetics, quasi-drugs, and drugs. The main component of the red color is carminic acid (CA). Carmine is an aluminum- or calcium-chelated product of CA. CA and carmine usually contain contaminating proteins, including a 38-kDa protein thought to be the primary allergen. Severe allergic reactions manifest as anaphylaxis. The aim of this study was to review all Japanese reported cases and propose useful diagnostic chart. METHODS All reported Japanese cases of cochineal dye-induced immediate allergy were reviewed, and newly registered cases were examined by skin prick test (SPT) with cochineal extract (CE) and measurement of CE and carmine-specific serum IgE test. Two-dimensional (2D) western blotting using patient serum was conducted to identify the antigen. RESULTS Twenty-two Japanese cases have been reported. SPT and the level of specific IgE test indicated that six cases should be newly registered as cochineal dye allergy. All cases were adult females, and all cases except three involved anaphylaxis; 13 cases involved past history of local symptoms associated with cosmetics use. Japanese strawberry juice and fish-meat sausage, and European processed foods (especially macarons made in France) and drinks were recent major sources of allergen. 2D western blotting showed that patient IgE reacted to the 38-kDa protein and other proteins. Serum from healthy controls also weakly reacted with these proteins. CONCLUSIONS SPT with CE and determination of the level of CE and carmine-specific IgE test are useful methods for the diagnosis of cochineal dye allergy.
Collapse
Affiliation(s)
- Naoko Takeo
- Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan; General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | - Satoshi Nakayama
- Clinical Diagnositic Division, Thermo Fisher Diagnostics, Tokyo, Japan
| | - Osamu Okamoto
- Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan; Department of Dermatology, Almeida Memorial Hospital, Oita, Japan
| | - Naoki Sugimoto
- Division of Food Additives, National Institute of Health Sciences Ministry of Health, Labour and Welfare, Tokyo, Japan
| | - Shinichi Sugiura
- Clinical Pharmacy, Doshisha Women's College of Liberal Arts, Kyoto, Japan
| | - Nayu Sato
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan; General Research and Development Institute, Hoyu Co., Ltd., Nagakute, Japan
| | | | - Masao Yamaguchi
- Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan
| | - Naoya Mitsui
- Clinic of Pediatrics, Mitsui Hospital, Yamagata, Japan
| | | | - Kayoko Suzuki
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Makoto Terada
- Division of Rheumatology, Department of Allergology, Itami City Hospital, Itami, Japan
| | - Akiyo Nagai
- Department of Dermatology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Junko Sowa-Osako
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Yutaka Hatano
- Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan
| | - Hiroshi Akiyama
- Division of Foods, National Institute of Health Sciences, Tokyo, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Nagoya, Japan
| | - Sakuhei Fujiwara
- Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
| |
Collapse
|
38
|
Suzuki K, Yagami A, Ito A, Kato A, Miyazawa H, Kanto H, Matsunaga K. Positive reactions to gold sodium thiosulfate in patch test panels (TRUE Test) in Japan: A multicentre study. Contact Dermatitis 2018; 80:114-117. [PMID: 30198192 PMCID: PMC6585663 DOI: 10.1111/cod.13105] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Revised: 07/27/2018] [Accepted: 07/27/2018] [Indexed: 11/29/2022]
Abstract
Background The proportion of positive test results with gold sodium thiosulfate included in a patch test panel (P‐GST) had been found to be greater than that with gold sodium thiosulfate 0.5% pet. by allergEAZE (A‐GST). Objectives To compare positive reactions to P‐GST and A‐GST, and to evaluate late reactions after the day (D) 7 reading. Methods A retrospective analysis was performed of 588 patients at participating departments (119 males; 469 females) who were patch tested with P‐GST and A‐GST in May 2015 to March 2016. Results Positive test reactions to P‐GST and A‐GST were observed in 15% and 6% of patients, respectively. Three patients reported a positive reaction occurring after the D7 reading. Conclusions Gold sodium thiosulfate often gives a positive reaction after 2 to 3 weeks, and, in such cases, the positive reaction may be sustained, so it is recommended to assess the reaction for up to 1 month after application.
Collapse
Affiliation(s)
- Kayoko Suzuki
- Department of Allergology, Fujita Health University Second Educational Hospital, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University Second Educational Hospital, Aichi, Japan
| | - Akiko Ito
- Department of Dermatology, Nagata Clinic, Niigata, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Atsuko Kato
- Department of Dermatology, Osaka Kaisei Hospital, Osaka, Japan
| | - Hitoshi Miyazawa
- Department of Dermatology, Nishi-Sapporo Skin and Allergy Clinic, Sapporo, Japan
| | - Hiromi Kanto
- Department of Dermatology, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan
| | - Kayoko Matsunaga
- Department of Allergology, Fujita Health University Second Educational Hospital, Aichi, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| |
Collapse
|
39
|
Mori Y, Okazaki F, Inuo C, Yamaguchi Y, Masuda S, Sugiura S, Fukuie T, Nagao M, Tsuge I, Yosikawa T, Yagami A, Matsunaga K, Fujisawa T, Ito K, Narita H, Kondo Y. Evaluation of serum IgE in peach-allergic patients with systemic reaction by using recombinant Pru p 7 (gibberellin-regulated protein). Allergol Immunopathol (Madr) 2018; 46:482-490. [PMID: 29786518 DOI: 10.1016/j.aller.2018.02.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Revised: 02/14/2018] [Accepted: 02/22/2018] [Indexed: 10/16/2022]
Abstract
BACKGROUND Lipid transfer protein (LTP) is a major fruit allergen. It has, however, recently been revealed that the systemic reaction in peach-allergic patients is related not only to LTP (Pru p 3) but also to gibberellin-regulated protein (Pru p 7). We investigated recombinant Pru p 7 (rPru p 7) for its potential use in worldwide standardization for the diagnosis of peach allergy. METHODS Natural Pru p 7 (nPru p 7) was purified from peach crude extract using a monoclonal antibody affinity column. Complementary DNA for Pru p 7 was cloned and expressed in Escherichia coli and Pichia pastoris. Serum immunoglobulin (Ig) E in peach-allergic patients was examined by enzyme-linked immunosorbent assay (ELISA) using nPru p 7 and rPru p 7 (E. coli product: erPru p 7 and P. pastoris product: prPru p 7). RESULTS Peach-allergic patients (n=27) were diagnosed and categorized into oral reaction (n=10) or systemic reaction (n=17). The nPru p 7 positivity based on serum IgE levels was 52% in the systemic-reaction group and 0% in the oral-reaction group (P<0.05). In the systemic-reaction group, there was no significant difference in reactivity between nPru p 7 and prPru p 7, but the reactivity of erPru p 7 was significantly lower than those of nPru p 7 and prPru p 7 (P<0.05). CONCLUSIONS We found that prPru p 7 exhibited reactivity in ELISA comparable to that of nPru p 7 for the diagnosis of peach allergy with systemic reaction.
Collapse
|
40
|
Tamagawa-Mineoka R, Masuda K, Yagami A, Nakamura M, Sato N, Matsunaga K, Katoh N. Food-induced anaphylaxis in two patients who were using soap containing foodstuffs. Allergol Int 2018; 67:427-429. [PMID: 29674155 DOI: 10.1016/j.alit.2018.02.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 02/11/2018] [Accepted: 02/27/2018] [Indexed: 12/20/2022] Open
|
41
|
Yamada T, Hasegawa S, Miyachi K, Date Y, Inoue Y, Yagami A, Arima M, Iwata Y, Yamamoto N, Nakata S, Matsunaga K, Sugiura K, Akamatsu H. Laminin-332 regulates differentiation of human interfollicular epidermal stem cells. Mech Ageing Dev 2018; 171:37-46. [PMID: 29555367 DOI: 10.1016/j.mad.2018.03.007] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 02/20/2018] [Accepted: 03/15/2018] [Indexed: 02/04/2023]
Abstract
Interfollicular epidermal stem cells (IFE-SCs) have self-renewal and differentiation potentials, and maintain epidermal homeostasis. Stem cells in vivo are regulated by the surrounding environment called niche to function properly, however, IFE-SC niche components are not fully understood. In order to elucidate the mechanisms of keeping epidermal homeostasis and of skin aging, and also to develop new therapeutic technologies for skin diseases, we searched for niche factors that regulate IFE-SCs. We found that laminin-332, a basement membrane component, was highly expressed at the tips of the dermal papillae, where IFE-SCs are localized, and that the stem cells by themselves expressed laminin-332. Knockdown of laminin-332 during the culture of IFE-SC-model cells to construct 3-dimensional epidermis in vitro resulted in failure to form proper structure, although no significant change was observed in either cell growth or apoptosis. Pre-coating of the culture insert with laminin-332 restored the normal formation of 3-dimensional epidermis. From these results, it was shown that laminin-332 is an essential niche component for the proper differentiation of IFE-SCs.
Collapse
Affiliation(s)
- Takaaki Yamada
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan; Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan; Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan.
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan; Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan; Nagoya University-MENARD Collaborative Chair, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan
| | - Katsuma Miyachi
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan
| | - Yasushi Date
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan; Nagoya University-MENARD Collaborative Chair, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa-ku, Nagoya, Aichi, Japan
| | - Yu Inoue
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan.
| | - Masaru Arima
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan
| | - Naoki Yamamoto
- Laboratory of Molecular Biology and Histochemistry, Joint Research Support Promotion Facility, Center for Research Promotion and Support, Fujita Health University, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan
| | - Satoru Nakata
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., 2-7 Torimicho, Nishi-ku, Nagoya, Aichi, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan.
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan
| | - Hirohiko Akamatsu
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, Aichi, Japan
| |
Collapse
|
42
|
Hide M, Igarashi A, Yagami A, Chinuki Y, Inomata N, Fukunaga A, Kaiser G, Wang J, Matsushima S, Greenberg S, Khalil S. Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study. Allergol Int 2018; 67:243-252. [PMID: 29102514 DOI: 10.1016/j.alit.2017.10.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Revised: 09/12/2017] [Accepted: 09/20/2017] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Omalizumab, a humanized anti-IgE monoclonal antibody, proved efficacious and well tolerated in patients with chronic spontaneous urticaria (CSU) refractory to H1 antihistamines (H1AH) in the POLARIS study (NCT02329223), a randomized, double-blind, placebo-controlled trial in East Asian patients. However, data in Japanese patients, who have specific baseline characteristics (e.g., low angioedema incidence, different background medications) that may impact clinical outcomes, are lacking. This pre-specified analysis presents additional patient-level data over time, pharmacokinetic and pharmacodynamics data for omalizumab and IgE, and efficacy and safety data for omalizumab in Japanese patients. METHODS Japanese patients (N = 105) were randomized 1:1:1 to omalizumab 300 mg, 150 mg, or placebo by subcutaneous injection every 4 weeks. Efficacy and safety were assessed primarily based on changes from baseline to Week 12 in weekly itch-severity scores (ISS7) and weekly urticaria activity scores (UAS7), and incidence of adverse events (AEs), respectively. Patient-level UAS7 data over time were also reviewed. RESULTS At Week 12, least squares mean (LSM) changes from baseline in ISS7 were greater with omalizumab vs. placebo (-9.54 and -7.29 for omalizumab 300 mg and 150 mg, respectively, vs. placebo [-5.17]). Corresponding LSM changes from baseline in UAS7 were -21.61 and -15.59 (vs. placebo [-10.88]). Most responders in the omalizumab 300 mg group displayed improvement of disease activity within 2-4 weeks and had well-controlled symptoms during the treatment period. Overall AE incidence was similar across treatment arms. CONCLUSIONS This subgroup analysis demonstrated that omalizumab is a well-tolerated, beneficial option for treatment of CSU in H1AH-refractory Japanese patients.
Collapse
|
43
|
Hasebe Y, Hasegawa S, Date Y, Nakata S, Yagami A, Iwata Y, Sugiura K, Akamatsu H. Localization of collagen type 5 in the papillary dermis and its role in maintaining stem cell functions. J Dermatol Sci 2017; 89:205-207. [PMID: 29146132 DOI: 10.1016/j.jdermsci.2017.10.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Revised: 09/11/2017] [Accepted: 10/14/2017] [Indexed: 12/21/2022]
Affiliation(s)
- Yuichi Hasebe
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Aichi, Japan; Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
| | - Seiji Hasegawa
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Aichi, Japan; Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
| | - Yasushi Date
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Aichi, Japan; Nagoya University-MENARD Collaborative Research Chair, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
| | - Satoru Nakata
- Research Laboratories, Nippon Menard Cosmetic Co., Ltd., Nagoya, Aichi, Japan
| | - Akiko Yagami
- Department of Allergology, Fujita Health University Second Educational Hospital, Nagoya, Aichi, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
| | - Hirohiko Akamatsu
- Department of Applied Cell and Regenerative Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
| |
Collapse
|
44
|
Hide M, Park HS, Igarashi A, Ye YM, Kim TB, Yagami A, Roh J, Lee JH, Chinuki Y, Youn SW, Lee SK, Inomata N, Choi JH, Fukunaga A, Wang J, Matsushima S, Greenberg S, Khalil S. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria. J Dermatol Sci 2017; 87:70-78. [DOI: 10.1016/j.jdermsci.2017.03.009] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2017] [Accepted: 03/14/2017] [Indexed: 10/19/2022]
|
45
|
Ito A, Nishioka K, Kanto H, Yagami A, Yamada S, Sugiura M, Yasunaga C, Yoshii K, Kobayashi H, Adachi A, Ikezawa Y, Washizaki K, Inui S, Miyazawa H, Oiso N, Nakata T, Matsunaga K. A multi-institutional joint study of contact dermatitis related to hair colouring and perming agents in Japan. Contact Dermatitis 2017; 77:42-48. [PMID: 28425114 DOI: 10.1111/cod.12783] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2016] [Revised: 01/18/2017] [Accepted: 01/23/2017] [Indexed: 12/01/2022]
Abstract
BACKGROUND In Japan, allergic contact dermatitis caused by hair colouring agents is a considerable problem for those occupationally exposed and also for consumers. Over the last 20 years, p-phenylenediamine (PPD) has been a common allergen, with ∼7% positive patch test reactions. OBJECTIVES To investigate which ingredients caused allergic contact dermatitis related to hair dye and perming solutions in Japan, to assess whether PPD is suitable for screening for hair dye allergy, and to propose allergens for a Japanese hairdresser series. METHODS We selected 19 hair cosmetic allergens, including PPD, Bandrowski's base, cysteamine HCl, and ammonium thioglycolate. Altogether 203 patients (26 males and 177 females) with suspected contact allergy to hair colouring or perming solutions at 14 hospitals in Japan were included. RESULTS The highest prevalence of positive reactions (35.1%) was for PPD. p-Methylaminophenol and o-aminophenol were often positive, both in the PPD-positive and in the PPD-negative patients. Moreover, cysteamine HCl often yielded positive test reactions. CONCLUSIONS PPD is insufficient to diagnose contact allergy caused by to hair dyes. We recommend 13 allergens to be included in a Japanese hairdresser series.
Collapse
Affiliation(s)
- Akiko Ito
- Department of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8520, Japan
| | | | - Hiromi Kanto
- Department of Dermatology, Toho University Omori Medical Centre, Ohta-ku, 143-8541, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, 470-1100, Japan
| | - Shigeki Yamada
- Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, 470-1100, Japan
| | - Mariko Sugiura
- Department of Environmental Dermatology and Allergology, Daiichi Clinic, Nagoya, 450-0008, Japan
| | - Chihiro Yasunaga
- Department of Dermatology, Gokeikai Osaka Kaisei Hospital, Ikeda, 532-0003, Japan
| | | | - Hiromi Kobayashi
- Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, 558-8585, Japan
| | - Atsuko Adachi
- Department of Dermatology, Hyogo Prefectural Kakogawa Medical Centre, Kakogawa, 675-8611, Japan
| | - Yuko Ikezawa
- Department of Dermatology, Chigasaki Municipal Hospital, Chigasaki, 253-0042, Japan
| | - Kumiko Washizaki
- Department of Dermatology, Toho University Omori Medical Centre, Ohta-ku, 143-8541, Japan
| | - Shigeki Inui
- Department of Regenerative Dermatology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan
| | | | - Naoki Oiso
- Faculty of Medicine, Department of Dermatology, Kindai University, Osakasayama, 589-0014, Japan
| | - Tokio Nakata
- Department of Dermatology, Showa University Fujigaoka Hospital, Yokohama, 227-8501, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, 470-1100, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, 470-1100, Japan
| |
Collapse
|
46
|
Yagami A, Aihara M, Ikezawa Z, Hide M, Kishikawa R, Morita E, Chinuki Y, Fukutomi Y, Urisu A, Fukushima A, Itagaki Y, Sugiura SI, Tanaka H, Teshima R, Kato Z, Noguchi E, Nakamura M, Saito H, Matsunaga K. Outbreak of immediate-type hydrolyzed wheat protein allergy due to a facial soap in Japan. J Allergy Clin Immunol 2017. [PMID: 28633942 DOI: 10.1016/j.jaci.2017.03.019] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Akiko Yagami
- Department of Allergology, Fujita Health University School of Medicine, Aichi, Japan
| | - Michiko Aihara
- Department of Dermatology, Yokohama City University School of Medicine, Kanagawa, Japan
| | - Zenro Ikezawa
- Department of Dermatology, Yokohama City University School of Medicine, Kanagawa, Japan
| | - Michihiro Hide
- Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Reiko Kishikawa
- Department of Allergy, National Hospital Organization Fukuoka Hospital, Fukuoka, Japan
| | - Eishin Morita
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan
| | - Yuko Chinuki
- Department of Dermatology, Shimane University Faculty of Medicine, Shimane, Japan
| | - Yuma Fukutomi
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Kanagawa, Japan
| | - Atsuo Urisu
- Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan
| | | | - Yasuharu Itagaki
- Department of Health and Nutrition, Hokkaido Bunkyo University, Hokkaido, Japan
| | - Shin-Ichi Sugiura
- Faculty of Pharmaceutical Sciences, Department of Clinical Pharmacy, Doshisha Women's College of Liberal Arts, Kyoto, Japan; Center for Research of Laboratory Animals and Medical Research Engineering, Nagoya University, Aichi, Japan
| | - Hiroyuki Tanaka
- Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan; Field of Biofunctional Control, Medical Information Science Division, the United Graduate School of Drug Discovery and Medical Information Science, Gifu University, Gifu, Japan
| | - Reiko Teshima
- Division of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan
| | - Zenichiro Kato
- United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan
| | - Emiko Noguchi
- Faculty of Medicine, Department of Medical Genetics, University of Tsukuba, Ibaraki, Japan
| | - Masashi Nakamura
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan
| | - Hirohisa Saito
- Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Aichi, Japan.
| |
Collapse
|
47
|
Watanabe S, Yagami A, Iwata Y, Nagai A, Kuroda M, Sugiura K, Matsunaga K. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients. J Dermatol 2017; 44:e148-e149. [PMID: 28516676 DOI: 10.1111/1346-8138.13885] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Soichiro Watanabe
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Akiyo Nagai
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Makoto Kuroda
- Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Kazumitsu Sugiura
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
| |
Collapse
|
48
|
Affiliation(s)
- Tomoko Inoue
- Department of Dermatology, Nishichita General Hospital, Tokai, Japan.
| | - Akiko Yagami
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
| | - Norito Ishii
- Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
| | - Takashi Hashimoto
- Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
| | - Kayoko Matsunaga
- Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan.,Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Toyoake, Japan
| |
Collapse
|
49
|
Iwata Y, Hasebe Y, Hasegawa S, Nakata S, Yagami A, Matsunaga K, Sugiura K, Akamatsu H. Dermal CD271+ Cells are Closely Associated with Regeneration of the Dermis in the Wound Healing Process. Acta Derm Venereol 2017; 97:593-600. [PMID: 28127619 DOI: 10.2340/00015555-2624] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Stem cells have recently been shown to play important roles in wound healing. The aim of this study was to investigate the role of dermal CD271+ cells in wound healing. Full-thickness wounds were produced on the backs of 5-year-old and 24-week-old mice, and time-course of wound closure, CD271+ cell counts, and gene expression levels were compared. Delayed wound healing was observed in 24-week-old mice. The peak of CD271+ cell increase was delayed in 24-week-old mice, and gene expression levels of growth factors in wounded tissue were significantly increased in 5-year-old mice. Dermal CD271+ cells purified by fluorescence-activated cell sorting (FACS) expressed higher growth factors than CD271- cells, suggesting that CD271+ cells play important roles by producing growth factors. This study also investigated dermal CD271+ cells in patients with chronic skin ulcers. Dermal CD271+ cells in patients were significantly reduced compared with in healthy controls. Thus, dermal CD271+ cells are closely associated with wound healing.
Collapse
Affiliation(s)
- Yohei Iwata
- Department of Dermatology, Fujita Health University School of Medicine, 1-98 Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Horita K, Horita D, Tomita H, Yasoshima M, Yagami A, Matsunaga K. Effects of different base agents on prediction of skin irritation by sodium lauryl sulfate using patch testing and repeated application test. Toxicology 2017; 382:10-15. [DOI: 10.1016/j.tox.2017.03.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2016] [Revised: 02/25/2017] [Accepted: 03/02/2017] [Indexed: 11/25/2022]
|